Answers are grounded in this paper and cite their sources.
Cell-based quadrivalent inactivated influenza vaccines (IIV4c) avoid egg-adaptive mutations found in egg-based production, improving vaccine effectiveness (VE). Studies demonstrate improved VE for IIV4c relative to egg-based quadrivalent inactivated influenza vaccines (IIV4).
No takes yet. Share an insight, caveat, or question.
McGovern et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: